95 related articles for article (PubMed ID: 15990722)
1. The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.
Melkersson K; Jansson E
Neuro Endocrinol Lett; 2005 Jun; 26(3):205-8. PubMed ID: 15990722
[TBL] [Abstract][Full Text] [Related]
2. Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.
Schmidt AJ; Krieg JC; Clement HW; Hemmeter UM; Schulz E; Vedder H; Heiser P
J Psychopharmacol; 2010 Mar; 24(3):349-54. PubMed ID: 18755815
[TBL] [Abstract][Full Text] [Related]
3. Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Celikyurt IK; Kayir H; Ulak G; Erden FB; Ulusoy GK; Uzbay TI
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):528-36. PubMed ID: 21168466
[TBL] [Abstract][Full Text] [Related]
4. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro.
Melkersson K
Eur Neuropsychopharmacol; 2004 Mar; 14(2):115-9. PubMed ID: 15013026
[TBL] [Abstract][Full Text] [Related]
5. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
6. Different effects of antipsychotic drugs on insulin release in vitro.
Melkersson K; Khan A; Hilding A; Hulting AL
Eur Neuropsychopharmacol; 2001 Oct; 11(5):327-32. PubMed ID: 11597818
[TBL] [Abstract][Full Text] [Related]
7. Effects of the atypical antipsychotic clozapine on insulin release in vitro.
Melkersson K; Jansson E
Neuro Endocrinol Lett; 2007 Dec; 28(6):854-60. PubMed ID: 18063937
[TBL] [Abstract][Full Text] [Related]
8. Risperidone- and quetiapine-induced cholestasis.
Wright TM; Vandenberg AM
Ann Pharmacother; 2007 Sep; 41(9):1518-23. PubMed ID: 17666578
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia.
Johnson DE; Yamazaki H; Ward KM; Schmidt AW; Lebel WS; Treadway JL; Gibbs EM; Zawalich WS; Rollema H
Diabetes; 2005 May; 54(5):1552-8. PubMed ID: 15855345
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.
Bai O; Xu H; Li XM
Life Sci; 2006 Jul; 79(6):570-4. PubMed ID: 16513140
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Oerther S; Ahlenius S
J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
[TBL] [Abstract][Full Text] [Related]
12. Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.
Hartfield AW; Moore NA; Clifton PG
Neuropsychopharmacology; 2006 Sep; 31(9):1938-45. PubMed ID: 16292324
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.
Manu P; Correll CU; Wampers M; van Winkel R; Yu W; Shiffeldrim D; Kane JM; De Hert M
Schizophr Res; 2013 Feb; 143(2-3):358-62. PubMed ID: 23231880
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics and diabetes mellitus.
Schwenkreis P; Assion HJ
World J Biol Psychiatry; 2004 Apr; 5(2):73-82. PubMed ID: 15179666
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
Li X; Rosborough KM; Friedman AB; Zhu W; Roth KA
Int J Neuropsychopharmacol; 2007 Feb; 10(1):7-19. PubMed ID: 16672106
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Smith JA; Goudie AJ
Exp Clin Psychopharmacol; 2002 Nov; 10(4):376-84. PubMed ID: 12498334
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.
Brinholi FF; Farias CC; Bonifácio KL; Higachi L; Casagrande R; Moreira EG; Barbosa DS
Biomed Pharmacother; 2016 Jul; 81():411-415. PubMed ID: 27261620
[TBL] [Abstract][Full Text] [Related]
18. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat.
Skarsfeldt T
Eur J Pharmacol; 1995 Aug; 281(3):289-94. PubMed ID: 8521912
[TBL] [Abstract][Full Text] [Related]
20. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
